Gujarat Themis Biosyn shares surged over 15% as the company announced plans to acquire 13 anti-TB and anti-infective brands ...

The buying on the counter came after Gujarat Themis Biosyn signed an Asset Purchase Agreement with Sanofi to acquire a ...

Gujarat Themis Biosyn Ltd has signed an asset purchase agreement to acquire Sanofi’s global portfolio of 13 anti-tuberculosis and anti-infective branded generics. The deal, subject to antitrust and ...

Idvynso is a new once-daily, two-drug oral regimen for adults with HIV-1 who are virologically suppressed and have no history ...

Tavapadon significantly improves motor function and activities of daily living in adults with early Parkinson disease compared with placebo.

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug ...

Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.

Coramitug is currently being investigated in the phase 3 CLEOPATTRA trial in approximately 1280 patients with ATTR-CM.

The deal, valued at €158 million, includes 13 established branded generic products with a presence across more than 55 ...

Wegovy (semaglutide) and Zepbound (tirzepatide) are commonly prescribed medications for weight management. Semaglutide, the ...

Uses, Dosage And Side Effects ...